Your account is not claimed yet. You can sign up with ORCID to claim your account.

Jean Marie Michot (Jean-Marie Michot, Jean M Michot)

ORCID

Publication Activity (10 Years)

Years Active: 2017-2023
Publications (10 Years): 24

Top Venues

American journal of hematology

Cancers

European journal of haematology

Clinical cancer research : an official journal of the American Association for Cancer Research

Gustave Roussy

This page only lists publications with an associated author ORCID identifier.

Affiliation History

Gustave Roussy Nov 2o 2013

France

MD :: Phase 1 Hematology

Publications

Jean Marie Michot, Cyril Quivoron, Clémentine Sarkozy, Alina Danu, Julien Lazarovici, Khalil Saleh, Yolla El-Dakdouki, Vincent Goldschmidt, Camille Bigenwald, Matteo Dragani, Rastislav Bahleda, Capucine Baldini, Julia Arfi-Rouche, Patricia Martin-Romano, Lambros Tselikas, Anas Gazzah, Antoine Hollebecque, Ludovic Lacroix, David Ghez, Veronique Vergé, Christophe Marzac, Sophie Cotteret, Wassila Rahali, Jean-Charles Soria, Christophe Massard, Olivier A Bernard, Peggy Dartigues, Valérie Camara-Clayette, Vincent Ribrag
Sequence analyses of relapsed or refractory diffuse large B-cell lymphomas unravel three genetic subgroups of patients and the GNA13 mutant as poor prognostic biomarker, results of LNH-EP1 study. American journal of hematology 98 (4) (2023)
Jean Marie Michot, Cyril Quivoron, Clémentine Sarkozy, Alina Danu, Julien Lazarovici, Khalil Saleh, Yolla El-Dakdouki, Vincent Goldschmidt, Camille Bigenwald, Matteo Dragani, Rastislav Bahleda, Capucine Baldini, Julia Arfi-Rouche, Patricia Martin-Romano, Lambros Tselikas, Anas Gazzah, Antoine Hollebecque, Ludovic Lacroix, David Ghez, Veronique Vergé, Christophe Marzac, Sophie Cotteret, Wassila Rahali, Jean-Charles Soria, Christophe Massard, Olivier A Bernard, Peggy Dartigues, Valérie Camara-Clayette, Vincent Ribrag
Sequence analyses of relapsed or refractory diffuse large B-cell lymphomas unravel three genetic subgroups of patients and the GNA13 mutant as poor prognostic biomarker, results of LNH-EP1 study. American journal of hematology 98 (4) (2023)
Fabio Andreozzi, Matteo Dragani, Cyril Quivoron, Fabien Le Bras, Tarek Assi, Alina Danu, Karim Belhadj, Julien Lazarovici, Sophie Cotteret, Olivier A Bernard, Vincent Ribrag, Jean Marie Michot
Precision Medicine Approach Based on Molecular Alterations for Patients with Relapsed or Refractory Multiple Myeloma: Results from the MM-EP1 Study. Cancers 15 (5) (2023)
Jean Marie Michot, Cyril Quivoron, Clémentine Sarkozy, Alina Danu, Julien Lazarovici, Khalil Saleh, Yolla El-Dakdouki, Vincent Goldschmidt, Camille Bigenwald, Matteo Dragani, Rastislav Bahleda, Capucine Baldini, Julia Arfi-Rouche, Patricia Martin-Romano, Lambros Tselikas, Anas Gazzah, Antoine Hollebecque, Ludovic Lacroix, David Ghez, Veronique Vergé, Christophe Marzac, Sophie Cotteret, Wassila Rahali, Jean-Charles Soria, Christophe Massard, Olivier A Bernard, Peggy Dartigues, Valérie Camara-Clayette, Vincent Ribrag
Sequence analyses of relapsed or refractory diffuse large B-cell lymphomas unravel three genetic subgroups of patients and the GNA13 mutant as poor prognostic biomarker, results of LNH-EP1 study. American journal of hematology (2023)
Sammara Chaubard, Amira Marouf, David Lavergne, François Lemonnier, Julien Rossignol, Aline Clavert, Rémy Gressin, Guillaume Cartron, Agathe Waultier-Rascalou, Jacques Vargaftig, Gilles Salles, Emmanuel Bachy, Hervé Ghesquières, Olivier Tournilhac, Adrien Chauchet, Steven Le Gouill, Gandhi Damaj, Luc-Matthieu Fornecker, David Sibon, Lucie Oberic, Jean Marie Michot, Philippe Gaulard, Olivier Hermine, Lucile Couronné, Arnaud Jaccard
Efficacy of a short sandwich protocol, methotrexate, gemcitabine, L-asparaginase and dexamethasone chemotherapy combined with radiotherapy, in localised newly diagnosed NK/T-cell lymphoma: A French retrospective study. British journal of haematology (2023)
Jean Marie Michot, Cyril Quivoron, Clémentine Sarkozy, Alina Danu, Julien Lazarovici, Khalil Saleh, Yolla El-Dakdouki, Vincent Goldschmidt, Camille Bigenwald, Matteo Dragani, Rastislav Bahleda, Capucine Baldini, Julia Arfi-Rouche, Patricia Martin-Romano, Lambros Tselikas, Anas Gazzah, Antoine Hollebecque, Ludovic Lacroix, David Ghez, Veronique Vergé, Christophe Marzac, Sophie Cotteret, Wassila Rahali, Jean-Charles Soria, Christophe Massard, Olivier A Bernard, Peggy Dartigues, Valérie Camara-Clayette, Vincent Ribrag
Sequence analyses of relapsed or refractory diffuse large B-cell lymphomas unravel three genetic subgroups of patients and the GNA13 mutant as poor prognostic biomarker, results of LNH-EP1 study. American journal of hematology (2023)
Jean Marie Michot, Cyril Quivoron, Clémentine Sarkozy, Alina Danu, Julien Lazarovici, Khalil Saleh, Yolla El-Dakdouki, Vincent Goldschmidt, Camille Bigenwald, Matteo Dragani, Rastislav Bahleda, Capucine Baldini, Julia Arfi-Rouche, Patricia Martin-Romano, Lambros Tselikas, Anas Gazzah, Antoine Hollebecque, Ludovic Lacroix, David Ghez, Veronique Vergé, Christophe Marzac, Sophie Cotteret, Wassila Rahali, Jean-Charles Soria, Christophe Massard, Olivier A Bernard, Peggy Dartigues, Valérie Camara-Clayette, Vincent Ribrag
Sequence analyses of relapsed or refractory diffuse large B-cell lymphomas unravel three genetic subgroups of patients and the GNA13 mutant as poor prognostic biomarker, results of LNH-EP1 study. American journal of hematology 98 (4) (2023)
Fabio Andreozzi, Matteo Dragani, Cyril Quivoron, Fabien Le Bras, Tarek Assi, Alina Danu, Karim Belhadj, Julien Lazarovici, Sophie Cotteret, Olivier A Bernard, Vincent Ribrag, Jean Marie Michot
Precision Medicine Approach Based on Molecular Alterations for Patients with Relapsed or Refractory Multiple Myeloma: Results from the MM-EP1 Study. Cancers 15 (5) (2023)
Monica Pierro, Capucine Baldini, Edouard Auclin, Hélène Vincent, Andreea Varga, Patricia Martin Romano, Perrine Vuagnat, Benjamin Besse, David Planchard, Antoine Hollebecque, Stéphane Champiat, Aurélien Marabelle, Jean Marie Michot, Christophe Massard, Laura Mezquita
Predicting Immunotherapy Outcomes in Older Patients with Solid Tumors Using the LIPI Score. Cancers 14 (20) (2022)
Vincent Camus, Aurélien Belot, Lucie Oberic, David Sibon, Herve Ghesquieres, Catherine Thieblemont, Christophe Fruchart, Olivier Casasnovas, Jean Marie Michot, Thierry Molina, Andre Bosly, Clémentine Joubert, Corinne Haioun, Emmanuelle Nicolas-Virelizier, Pierre Feugier, Olivier Fitoussi, Richard Delarue, Herve Tilly
Outcomes of elderly diffuse large B-cell lymphoma patients treated with R-CHOP: 10-year follow-up of the LNH03-6B trial. Blood advances (2022)
Maria-Victoria Mateos-Manteca, Felipe Prosper, Jesús Martín-Sánchez, Enrique M Ocio, Albert Oriol, Cristina Motlló, Jean Marie Michot, Isidro Jarque, Rebeca Iglesias, María Solé, Sara Martínez, Carmen Kahatt, Salvador Fudio, Gema Corral, Ali Zeaiter, Lola Montilla, Vincent Ribrag
Phase I study of plitidepsin in combination with bortezomib and dexamethasone in patients with relapsed/refractory multiple myeloma. Cancer medicine (2022)
Alberto Picca, Giulia Berzero, Kevin Bihan, Vincent Jachiet, Edouard Januel, Marc Coustans, Cecile Cauquil, Julie Perrin, Pablo Berlanga, Nora Kramkimel, Bethsabée Garel, Perrine Devic, François Ducray, Marion Benazra, Flavie Bompaire, Delphine Leclercq, Jean Marie Michot, Samy Ammari, Dimitri Psimaras
Longitudinally Extensive Myelitis Associated With Immune Checkpoint Inhibitors. Neurology(R) neuroimmunology & neuroinflammation 8 (3) (2021)
Pamela Abdayem, Nathalie Ibrahim, Yolla El Dakdouki, Christophe Willekens, David Ghez, Julia A Rouche, Peggy Dartigues, Romain Desmaris, Alina Danu, Julien Rossignol, Julien Lazarovici, Christophe Fermé, Vincent Ribrag, Jean Marie Michot
Attenuated cytarabine, etoposide, dexamethasone plus rituximab (R-Mini-CYVE) regimen for patients with relapsed or refractory B-cell non-Hodgkin's lymphoma not eligible for intensive chemotherapy. European journal of haematology 106 (4) (2021)
Nicolas Leupin, Pier Luigi Luigi Zinzani, Franck Morschhauser, Stéphane Dalle, Marie Maerevoet, Jean Marie Michot, Vincent Ribrag, Fritz Offner, Marie Beylot-Barry, Hélène Moins-Teisserenc, Karen Zwaenepoel, Koen de Winne, Maxime Battistella, Anna Hultberg, Domenica Gandini, Mahan Moshir, Julie Jacobs, Tim Delahaye, Aitzaz Khan, Piotr Zabrocki, Karen Silence, Luc van Rompaey, Christophe Borg, Giovanna Motta, Federica Melle, Angelica Calleri, Patrick Pauwels, Hans de Haard, Stefano Pileri, Martine Bagot
Cusatuzumab for treatment of CD70-positive relapsed or refractory cutaneous T-cell lymphoma. Cancer (2021)
Mihaela Aldea, Jean Marie Michot, Francois-Xavier Danlos, Antoni Ribas, Jean-Charles Soria
Repurposing of Anticancer Drugs Expands Possibilities for Antiviral and Anti-Inflammatory Discovery in COVID-19. Cancer discovery 11 (6) (2021)
Jean Marie Michot, Severine Mouraud, Julien Adam, Julien Lazarovici, Camille Bigenwald, Charlotte Rigaud, Lambros Tselikas, Peggy Dartigues, Alina Danu, Amélie Bigorgne, Veronique Minard, David Ghez, Aurélien Marabelle, Laurence Zitvogel, Vincent Ribrag
CD8+ T Lymphocytes Immune Depletion and LAG-3 Overexpression in Hodgkin Lymphoma Tumor Microenvironment Exposed to Anti-PD-1 Immunotherapy. Cancers 13 (21) (2021)
Michael Collins, Jean Marie Michot, Christophe Bellanger, Charlotte Mussini, Karim Benhadji, Christophe Massard, Franck Carbonnel
Notch inhibitors induce diarrhea, hypercrinia and secretory cell metaplasia in the human colon. EXCLI journal 20 (2021)
Anastasia Dupré, Jean Marie Michot, Amélie Schoeffler, Laure Frumholtz, Barouyr Baroudjian, Julie Delyon, Céleste Lebbe, Olivier Lambotte
Haemophagocytic lymphohistiocytosis associated with immune checkpoint inhibitors: a descriptive case study and literature review. British journal of haematology 189 (5) (2020)
Khalil Saleh, Jean Marie Michot, Antoine Schernberg, Julien Lazarovici, Claude Chahine, Alina Danu, Nadine Khalife-Saleh, Julien Rossignol, David Ghez, Valentine Martin, Renaud Mazeron, Christophe Fermé, Angela Boros, Vincent Ribrag, Theodore Girinsky
Repeated courses of low-dose 2 × 2 Gy radiation therapy in patients with indolent B-cell non-Hodgkin lymphomas. Cancer medicine 9 (11) (2020)
Clémentine Sarkozy, Franck Morschhauser, Sydney Dubois, Thierry Molina, Jean Marie Michot, Peggy Cullières-Dartigues, Benjamin Suttle, Lionel Karlin, Steven Le Gouill, Jean-Michel Picquenot, Romain Dubois, Hervé Tilly, Charles Herbaux, Fabrice Jardin, Gilles Salles, Vincent Ribrag
A LYSA Phase Ib Study of Tazemetostat (EPZ-6438) plus R-CHOP in Patients with Newly Diagnosed Diffuse Large B-Cell Lymphoma (DLBCL) with Poor Prognosis Features. Clinical cancer research : an official journal of the American Association for Cancer Research 26 (13) (2020)
Jean Marie Michot, Maxime Annereau, Alina Danu, Clémence Legoupil, Louis Bertin, Claude Chahine, Nadia Achab, Anna Antosikova, Ariane Cerutti, Julien Rossignol, David Ghez, Christophe Willekens, Peggy Dartigues, Julien Lazarovici, Francois Lemare, Vincent Ribrag
High-dose cyclophosphamide for hard-to-treat patients with relapsed or refractory B-cell non-Hodgkin's lymphoma, a phase II result. European journal of haematology 104 (4) (2020)
Guillaume Manson, Alexandre Thibault Jacques Maria, Florence Poizeau, François-Xavier Danlos, Marie Kostine, Solenn Brosseau, Sandrine Aspeslagh, Pauline Du Rusquec, Maxime Roger, Maud Pallix-Guyot, Marc Ruivard, Léa Dousset, Laurianne Grignou, Dimitri Psimaras, Johan Pluvy, Gilles Quéré, Franck Grados, Fanny Duval, Frederic Bourdain, Gwenola Maigne, Julie Perrin, Benoit Godbert, Beatris Irina Taifas, Alexandra Forestier, Anne-Laure Voisin, Patricia Martin-Romano, Capucine Baldini, Aurélien Marabelle, Christophe Massard, Jérôme Honnorat, Olivier Lambotte, Jean Marie Michot
Worsening and newly diagnosed paraneoplastic syndromes following anti-PD-1 or anti-PD-L1 immunotherapies, a descriptive study. Journal for immunotherapy of cancer 7 (1) (2019)
Timothy A Yap, Jane N Winter, Lisa Giulino-Roth, Jemma Longley, Juanita Lopez, Jean Marie Michot, John P Leonard, Vincent Ribrag, Michael T McCabe, Caretha L Creasy, Melissa Stern, Teodora Pene Dumitrescu, Xiaowei Wang, Steve Frey, Jennifer Carver, Thierry Horner, Choon Oh, Ahmed Khaled, Arindam Dhar, Peter W M Johnson
Phase I Study of the Novel Enhancer of Zeste Homolog 2 (EZH2) Inhibitor GSK2816126 in Patients with Advanced Hematologic and Solid Tumors. Clinical cancer research : an official journal of the American Association for Cancer Research 25 (24) (2019)
Jean Marie Michot, Lina Benajiba, Laura Faivre, Capucine Baldini, Lelia Haddag, Clement Bonnet, Christophe Massard, Frederic Bigot, Camille Bigenwald, Benjamin Verret, Zoé A P Thomas, Andrea Varga, Anas Gazzah, Antoine Hollebecque, David Ghez, Julien Lazarovici, Rastilav Balheda, Aurore Jeanson, Sophie Postel-Vinay, Alina Danu, Jean-Charles Soria, Xavier Paoletti, Vincent Ribrag
Outcomes and prognostic factors for relapsed or refractory lymphoma patients in phase I clinical trials. Investigational new drugs 36 (1) (2017)

Jean Marie Michot.css-eqlu8i{font-size:small;padding-left:4px;} (Jean-Marie Michot, Jean M Michot)

Publication Activity (10 Years)

Top Topics

Top Venues

Jean Marie Michot (Jean-Marie Michot, Jean M Michot)